跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,364 条关于
“classical complement pathway”
全部
8,364
临床试验
2,555
药物
127
机构
19
资讯
5,663
去年
Dianthus Therapeutics Completes Enrollment in Phase 2 MaGic Trial for Generalized Myasthenia Gravis Treatment
上个月
Tanruprubart Demonstrates Rapid Recovery in Guillain-Barré Syndrome, Supporting 2026 BLA Submission
去年
Ruxoprubart Receives FDA IND Clearance for Phase II Trials in IgAN and Dermatomyositis
9个月前
Real-World Safety Data Confirms Long-Term Tolerability of ENJAYMO in Cold Agglutinin Disease Patients
去年
Recordati Acquires Global Rights to Sanofi's CAD Treatment Enjaymo in $825M Deal
去年
Annexon Biosciences' ANX005 Shows Promise in Guillain-Barré Syndrome Treatment
去年
ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis
去年
Nephrology Month in Review: December 2024
去年
Riliprubart Shows Promise in CIDP Treatment with Significant Neurofilament Light Reduction
去年
ANX007 Shows Promise in Preserving Vision in Dry AMD Patients with Geographic Atrophy
第 1 页，共 567 页
上一页
下一页
